Table 1.
Baseline Characteristics of All Randomized Study Participants
| Variable | Control group (n = 690) | Telemonitoring group (n = 690) |
|---|---|---|
| Demographic characteristics | ||
| Age, mean (SD), y | 66 (15) | 67 (14) |
| Sex, no. (%) | ||
| Female | 329 (47.7) | 329 (47.7) |
| Male | 361 (52.3) | 361 (52.3) |
| Race, no. (%) | ||
| Black or African American | 83 (12.0) | 83 (12.0) |
| Asian | 7 (1.0) | 9 (1.3) |
| White | 571 (82.8) | 575 (83.3) |
| Other | 11 (1.6) | 10 (1.4) |
| Unknown | 18 (2.6) | 13 (1.9) |
| Ethnicity, no. (%) | ||
| Hispanic/Latino | 24 (3.5) | 29 (4.2) |
| Non-Hispanic/Latino | 643 (93.2) | 640 (92.8) |
| Unknown | 23 (3.3) | 21 (3.0) |
| Body mass index, mean (SD), kg/m2 | 28.9 (7.1) | 29.0 (7.7) |
| Comorbid conditions, no. (%) | ||
| Myocardial infarction | 101 (14.6) | 82 (11.9) |
| Congestive heart failure | 185 (26.8) | 200 (29.0) |
| Peripheral vascular disease | 179 (25.9) | 170 (24.6) |
| Cerebrovascular disease | 150 (21.7) | 166 (24.1) |
| Dementia | 33 (4.8) | 26 (3.8) |
| Chronic pulmonary disease | 219 (31.7) | 224 (32.5) |
| Ulcer | 40 (5.8) | 31 (4.5) |
| Mild liver disease | 104 (15.1) | 112 (16.2) |
| Diabetes mellitus | 180 (26.1) | 185 (26.8) |
| Hemiplegia | 24 (3.5) | 33 (4.8) |
| Moderate to severe renal disease | 241 (34.9) | 245 (35.5) |
| Metastatic solid tumor | 80 (11.6) | 92 (13.3) |
| AIDS | 5 (0.7) | 2 (0.3) |
| Rheumatologic disease | 26 (3.8) | 27 (3.9) |
| Other cancer | 227 (32.9) | 224 (32.5) |